Free Trial

Dolby Laboratories (NYSE:DLB) Updates FY 2025 Earnings Guidance

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Dolby Laboratories updated its FY 2025 earnings guidance, projecting an EPS of $3.880-4.030 and revenue of $1.3 billion-$1.4 billion.
  • Several analysts reaffirmed their ratings on Dolby, with Barrington Research setting a price target of $100.00 and Tigress Financial offering a target of $112.00.
  • The company has reported a dividend yield of 1.8%, reflecting a quarterly dividend payment of $0.33 per share for shareholders.
  • Five stocks to consider instead of Dolby Laboratories.

Dolby Laboratories (NYSE:DLB - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 3.880-4.030 for the period, compared to the consensus earnings per share estimate of 3.970. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Dolby Laboratories also updated its Q4 2025 guidance to 0.610-0.760 EPS.

Dolby Laboratories Stock Performance

Shares of DLB stock traded down $5.15 on Friday, hitting $70.19. The stock had a trading volume of 818,905 shares, compared to its average volume of 299,803. The firm has a market capitalization of $6.74 billion, a price-to-earnings ratio of 25.71 and a beta of 0.91. The stock's 50 day moving average is $74.92 and its 200-day moving average is $77.57. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.06. The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.62%. The business's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.71 earnings per share. Equities analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Tuesday, August 12th. This represents a $1.32 annualized dividend and a yield of 1.9%. Dolby Laboratories's dividend payout ratio is currently 48.35%.

Analyst Upgrades and Downgrades

DLB has been the topic of several recent analyst reports. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday, May 2nd. Rosenblatt Securities reaffirmed a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a report on Friday. Tigress Financial initiated coverage on shares of Dolby Laboratories in a report on Thursday, May 15th. They issued a "buy" rating and a $112.00 price target on the stock. Finally, Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Friday, May 30th.

Check Out Our Latest Report on Dolby Laboratories

Insider Activity at Dolby Laboratories

In related news, SVP John D. Couling sold 675 shares of the stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $75.04, for a total value of $50,652.00. Following the completion of the transaction, the senior vice president owned 121,151 shares in the company, valued at $9,091,171.04. This represents a 0.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Mark Andrew Sherman sold 15,000 shares of the firm's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the transaction, the executive vice president owned 62,397 shares of the company's stock, valued at approximately $4,681,022.94. This trade represents a 19.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold 116,724 shares of company stock worth $8,764,043 in the last 90 days. Corporate insiders own 38.39% of the company's stock.

Institutional Trading of Dolby Laboratories

Hedge funds have recently bought and sold shares of the company. Focus Partners Wealth purchased a new stake in shares of Dolby Laboratories in the first quarter worth approximately $390,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker's stock worth $19,131,000 after purchasing an additional 12,598 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker's stock worth $20,043,000 after purchasing an additional 171,288 shares in the last quarter. Finally, Royal Bank of Canada lifted its position in shares of Dolby Laboratories by 3.5% in the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker's stock worth $5,491,000 after purchasing an additional 2,298 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Articles

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines